92.64
BATS BZX Real-Time Price
As of 2:06pm ET
 +1.62 / +1.78%
Today’s Change
83.19
Today|||52-Week Range
125.86
-4.21%
Year-to-Date
Company News For Sep 20, 2018
10:30am / Zacks.com - Paid Partner Content
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Sep 14 / Zacks.com - Paid Partner Content
Bristol-Myers' MM Drug Empliciti Application Validated by EMA
Sep 19 / Zacks.com - Paid Partner Content
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Sep 14 / Zacks.com - Paid Partner Content
AbbVie Faces California Insurance Department Suit for Humira
Sep 19 / Zacks.com - Paid Partner Content
3 Things You Might Be Overlooking With AbbVie
Sep 14 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks to Buy Right Now
Sep 18 / MotleyFool.com - Paid Partner Content
A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis
Sep 14 / MotleyFool.com - Paid Partner Content
Is Galapagos NV a Buy Now?
Sep 18 / MotleyFool.com - Paid Partner Content
Should Value Investors Consider AbbVie (ABBV) Stock Now?
Sep 13 / Zacks.com - Paid Partner Content
Pfizer's Skin Disease Candidates Positive in Mid-Stage Study
Sep 17 / Zacks.com - Paid Partner Content
AbbVie Gets FDA Nod for Venclexta Label Expansion in Leukemia
Sep 12 / Zacks.com - Paid Partner Content
Corporate America is spending more on buybacks than anything else
Sep 17 / CNNMoney.com
Vertex Completes Enrollment in Triple Combination Studies
Sep 07 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: JPMorgan, Mastercard, AbbVie, CVS Health and Estee...
Sep 17 / Zacks.com - Paid Partner Content
Lilly, Teva, Pfizer & Others Await FDA Decisions in September
Sep 07 / Zacks.com - Paid Partner Content
Top Stock Reports for JPMorgan, Mastercard & AbbVie
Sep 14 / Zacks.com - Paid Partner Content